Several studies have demonstrated the potential of ctDNA (Tumor Protein p53 [TP53], Retinoblastoma 1 [RB1]) as a valuable tool for the diagnosis and prognosis of SCLC (72, 73). This evidence concerns the gene TP53 and small cell lung carcinoma.